The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT06047080
Brief Title: An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma

First Submitted : September 14, 2023
First Submitted that Met QC Criteria : September 14, 2023
First Posted : September 21, 2023

Last Update Submitted that Met QC Criteria : June 6, 2024
Last Update Posted : June 7, 2024